Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1048P is a non-functional pseudogene homologous to *RNA, U6 small nuclear* genes, which normally code for U6 snRNA, a component of the spliceosome critical for mRNA splicing. RNU6-1048P is one of many processed pseudogenes in the human genome; it does not encode a protein or functional RNA and is not considered a drug or therapeutic target. While some pseudogenes are increasingly recognized for regulatory functions (such as acting as competing endogenous RNAs or influencing parent gene regulation), there is currently no evidence that RNU6-1048P has any functional role or associated pathology[1][4]. Thus, its mention as a receptor or drug target is incorrect. Key context: Pseudogenes are often non-functional DNA sequences related to real genes. RNU6-1048P particularly appears in databases such as GeneCards purely as a pseudogene, with no functional annotation[1]. Some U6 pseudogenes can be involved in chimeric RNA formation (e.g., U6/L1 chimeric pseudogenes), but this is a byproduct of retrotransposition and is not a sign of classic molecular targeting or activity[3]. U6 snRNA (the functional gene product family) is important for splicing but RNU6-1048P does not code for this RNA[5]. Summary: RNU6-1048P is a pseudogene with no established function, disease link, or drug interaction, and is incorrectly classified if treated as a molecular or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1048, pseudogene (RNU6-1048P).